House of Commons
As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.
NICE RECOMMENDATIONS FOR ALZHEIMER'S DISEASE DRUGS
EDM #947
Tabled 02 November 2010
2010-12 Session
That this House notes that dementia is a devastating illness which affects over 800,000 people in the UK, two-thirds of them suffering from Alzheimer's disease and with only about a tenth receiving drug treatment; understands that for patients suffering in all stages of the disease some drug treatments can help to alleviate symptoms but that currently there are no National Institutefor Health and Clinical Excellence (NICE) recommended treatment options for mild or severe forms of the disease; believes that the current NICE technology appraisal of Alzheimer's diseease will allow drugs, which can improve the symptoms of Alzheimer's disease, to be more widely available; congratulates NICE on its recently published draft guidance on Alzheimer's disease, which recommends the use of donepezil, galantamine and rivastigmine for Alzheimer's patients suffering from a mild and moderate form of the disease as well as recommending memantine for use in patients suffering from severe Alzheimer's and some moderate Alzheimer's patients; welcomes that there will now be NICE recommended treatment options for patients suffering at all stages of Alzheimer's disease, which will help to alleviate the terrible symptoms for thousands of patients; further notes that NICE has recognised the benefits that memantine can have on patients suffering from behavioural symptoms of Alzheimer's disease, including aggression and agitation; further welcomes the contribution this could have towards reducing the prescriptions of anti-psychotic chemical cosh drugs; and looks forward to the current draft recommendations being finalised unchanged at the end of the consultation period.

Signatures (37)

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
In addition to the sponsors, the following Members have signed to support the motion.
These members had previously signed the motion, but have now withdrawn their support. The date shown is when the Member withdrew their signature from the motion.